Method of targeting conjugate molecules to mitochondria

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S297000, C435S375000

Reexamination Certificate

active

06867197

ABSTRACT:
The present invention relates to genetic mutations in mitochondrial cytochrome c oxidase genes that segregate with Alzheimer's disease (AD). The invention provides methods for detecting such mutations, as a diagnostic for Alzheimer's Disease, either before or after the onset of clinical symptoms. The invention further provides treatment of cytochrome c oxidase dysfunction.

REFERENCES:
patent: 5185244 (1993-02-01), Wallace
patent: WO 9119815 (1991-12-01), None
patent: WO 9409162 (1994-04-01), None
Anderson et al., “Sequence and Organization of the Human Mitochondrial Genome,” Nature 290:457-465 (1981).
Barany et al., PCR Methods and App. 1:5-16 (1991).
Bennett et al., “Cytochrome Oxidase Inhibition A Novel Animal Model of Alzheimer's Disease,” J. of Geriatric Psychiatry and Neurology 5:93-101 (1992).
Bowling et al., “Age-Dependent Impairment of Mitochondrial Function in Primate Brain,” J. of Neurochemistry 60(5):1964-1967 (1992).
Chandrasekaran et al., “Differential Expression of Cytochrome Oxidase (COX) Genes in Different Regions of Monkey Brain,” J. of Neuroscience Research 32:415-423 (1992).
Chandrasekaran et al., “Localization of Cytochrome Oxidase (COX) Activity and COX mRNA in Perirhinal and Superior Temporal Sulci of The Monkey Brian,” Brain Research 606:213-219 (1993).
Conner et al., “Detection of Sickle Cell .beta . . sup.s -globin Allele by Hybridization with Synthetic Oligonucleotides,” PNAS USA 80:278-282 (1983).
Davis et al., “Mutations in Mitochondrial Cytochrome c Oxidase Genes Segregate with Late-Onset Alzheimer Disease,” PNAS USA 94: 4526-4531, (1997).
Douglas C. Wallace, “Mitochondrial Genetics: A Paradigm for Aging and Degenerative Diseases,” Science 256:628-632 (1992).
Erlich et al., “Specific DNA Amplification,” Nature 331:461-462 (1988).
Fodor et al., “Light-directed, Spatially Addressable Parallel Chemical Synthesis,” Research Article 767-773 (1991).
Francis Barany, “Genetic Disease Detection and DNA Amplification Using Cloned Thermostable Ligase,” PNAS USA 88 :189-193 (1991).
Francis Barany, “Genetic Disease Detection and DNA Amplification Using Cloned Thermostable Ligase,” PNAS USA 88 ;189-193 (1991).
Ghosh et al., “Using of Maleimide-thiol Coupling Chemistry for Efficient Syntheses of Oligonucleotide-enzyme Conjugate Hybridization Probes,” Bioconjugate Chem. 1(1)71-76 (1990).
Gibbs et al., “Detection of Single DNA Base Differences by Competitive Oligonucleotide Priming,” Nucleic Acids Research 2437-2448 (1989).
Gingeras et al., “Use of Self-sustained Sequence Replication Amplification Reaction to Analyze and Detect Mutations in Zidovudine-resistant Human Immunodeficiency Virus,” J. of Infectious Diseases 164:1066-1074 (1991).
Howell et al., “Leber Hereditary Optic Neuropathy: Identification of The Same Mitochondrial ND1 Mutation in Six Pedigrees,” Am. J. Hum. Genet. 49:939-950 (1991).
Ishii and Ghosh, “Bead-based Sandwich Hybridization Characteristics of Oligonucleotide-Alkaline Phosphatase Conjugates and Their Potential for Quantitating Target RNA Sequences,” Bioconjugate Chem. 4(1):34-41 (1993).
Jablonski et al., “Preparation of Oligodeoxynucleotide-alkaline Phosphatase Conjugates and Their Use as Hybridization Probes,” Nucleic Acids Research 14(15):6115-6129 (1986).
Jenner, P. Acta Neurol. Scand. 84:6-15 (1991).
Kish, et al., “Brian Cytochrome Oxidase in Alzheimer's Disease,” J. of Neurochemistry 59(2):776-779 (1993).
Kuppuswamy et al., “Single Nucleotide Primer Extension to Detect Genetic Diseases: Experimental Application to Hemophilia B (Factor IX) and Cystic Fibrosis Genes, ” PNAS USA 88:1143-1147 (1991).
Landegren et al., “A Ligase-mediated Gene Detection Technique,” Science 241:1077-1080 (1988).
Li et al., “Enzyme-linked Synthetic Oligonucleotide Probes: Non-Radioactive Detection of Enterotoxigenic Escherichia Coli in Faecal Specimens,” Nucleic Acids Research 15(13):5275-5287 (1987).
Luft, “The Development of Mitochondrial Medicine,” PNAS USA 91(19): 8731-8738, (1994).
Matthews and Kricka, “Analytical Strategies for The Use of DNA Probes,” Analytical Biochemistry 169:1-25 (1988).
Newton et al., “Analysis of Any Point Mutation in DNA. The Amplification Refractory Mutation System (ARMS),”, Nucleic Acids Research 17(7):2503-2517 (1989).
Nickerson et al., “Automated DNA Diagnostics Using An ELISA-based Oligonucleotide Ligation Assay,” PNAS USA 87:8923-8927 (1990).
Parker et al., “Cytochrome Oxidase Mutations Aiding Diagnosis of Sporadic Alzheimer's Disease,” Biotechnology Advances 15(2): 462-463, (1997).
Parker, Davis Ann. Neurol. 26:719-723 (1989).
Parker et al. “Cytochrome Oxidase Deficiency in Alzheimer's Disease,” Neurology 40:1302-1303 (1990).
Partridge et al., Arch. Biochem. Biophys. 310:210-217 (1994).
Power et al., “Nucleotide Sequence of Human Mitochondrial Cytochrome C Oxidase II cDNA,” Nucleic Acids Research 17(16): 6734, (1989).
Richman et al., “Human Immunodeficiency Virus Type I Mutants Resistant to Nonnucleotide Inhibitors of Reverse Transcriptase Arise in Tissue Culture,” Proc. Natl. Acad. Sci. USA 88:11241-11245 (1991).
Saiki et al., “Genetic Analysis of Amplified DNA with Immobilized Sequence-Specific Oligonucleotide Probes,” Proc. Natl. Acad. USA 86:6230-6234 (1989).
Shoffner et al., “Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients,” Genomics 17:171-184 (1993).
Simonian et al., “Functional Alterations in Alzheimer's Disease: Diminution of Cytochrome Oxidase in the Hippocampal Formation,” J. of Neuropathy and Experimental Neurology 52(6):580-585 (1993).
Suggs et al., “Use of Synthetic Oligonucleotides as Hybridization Probes: Isolation of Cloned cDNA Sequences for Human .beta . . . sub.2—microglobulin,” Proc. Natl. Acad. Sci. USA 78(11):6613-6617 (1981).
Suzuki et al., “Diabetes With Mitochondrial Gene tRNA Lys Mutation,” Diabetes Care 17(12): 1428-1432, Dec. (1994).
Syvanen et al., “A Primer-guided Nucleotide Incorporation Assay in The Genotyping of Apolipoprotein E,” Genomics 8:684-692 (1990).
Wallace, et al., “Mitochondrial DNA Mutations in Epilepsy and Neurological Disease”, Epilepsia 35(1):S43-S50 (1994).
Wu and Wallace, “The Ligation Amplification Reaction (LAR)-amplification of Specific DNA Sequences Using Sequential Rounds of Template-dependent Ligation,” Genomics 4:560-569 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of targeting conjugate molecules to mitochondria does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of targeting conjugate molecules to mitochondria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of targeting conjugate molecules to mitochondria will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3405982

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.